Collaboration to leverage AbbVie’s expertise in biotherapeutic drug development and commercialization together with ADARx’s proprietary RNA technology to advance next-generation siRNA therapies across neuroscience, immunology and oncology NORTH CHICAGO, ILL & SAN… Read More
CHARLOTTETOWN, PE – The Canadian Alliance for Skills and Training in Life Sciences (CASTL) is pleased to announce the appointment of Paula Casalino, P.Eng., Vice President, Operations – Canada at IPS Integrated… Read More
Canada’s growing ambitions to lead in vaccine and biologics manufacturing face a serious bottleneck: a shortage of skilled workers. According to two new reports from the Canadian Alliance for Skills and… Read More
Innovative Pharmaceutical Industry Contributed $18.4 Billion to the Canadian Economy in 2022 OTTAWA, QC – New data released by Statistics Canada confirms that Canada’s innovative pharmaceutical industry is more than a contributor to… Read More
ABCL575 is a novel, half-life extended anti-OX40L monoclonal antibody that is being developed for the treatment of moderate-to-severe atopic dermatitis (AD) In preclinical studies, ABCL575 shows potent inhibition of inflammatory… Read More
